Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 5:16 pm Purchase |
2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Lilly Ventures Fund I LLC | 2,404,069 5.200% |
2,404,069 (New Position) |
Filing History |
| 2021-02-12 5:08 pm Sale |
2020-12-31 | 13G | Surface Oncology, Inc. SURF |
Lilly Ventures Fund I LLC | 3,447,817 8.500% |
-36,801 (-1.06%) |
Filing History |
| 2021-02-12 4:59 pm Sale |
2020-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Lilly Ventures Fund I LLC | 102,742 5.400% |
-3,227 (-3.04%) |
Filing History |
| 2020-06-08 4:04 pm Sale |
2020-05-11 | 13D | Protagonist Therapeutics, Inc. PTGX |
Lilly Ventures Fund I LLC | 1,559,060 4.500% |
-540,422 (-25.74%) |
Filing History |